tiprankstipranks

Molecular Partners price target raised to CHF 4.50 from CHF 3.70 at JPMorgan

JPMorgan raised the firm’s price target on Molecular Partners to CHF 4.50 from CHF 3.70 and keeps a Neutral rating on the shares.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue